RxSight
- Country
- πΊπΈUnited States
- Ownership
- -
- Employees
- 374
- Market Cap
- -
- Introduction
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Clinical Trials
8
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)β’ Click on a phase to view related trials
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
- Conditions
- CataractAphakia
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- RxSight, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT05202808
- Locations
- πΊπΈ
Slade & Baker Vision, Houston, Texas, United States
πΊπΈVold Vision, Fayetteville, Arkansas, United States
πΊπΈReeve Woods Eye Center, Chico, California, United States
Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes
- Conditions
- CataractAphakia
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- RxSight, Inc.
- Target Recruit Count
- 79
- Registration Number
- NCT04529616
- Locations
- π²π½
CODET Vision Institute, Tijuana, Mexico
A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus
- Conditions
- AphakiaCataractPresbyopia
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- RxSight, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT04177771
- Locations
- πΊπΈ
Vold Vision, Fayetteville, Arkansas, United States
A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)
- Conditions
- AphakiaCataract
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2021-06-11
- Lead Sponsor
- RxSight, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04005586
- Locations
- πΊπΈ
Cleveland Eye Clinic, Brecksville, Ohio, United States
πΊπΈVance Thompson Vision Clinic, Sioux Falls, South Dakota, United States
Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual Outcomes
- Conditions
- AphakiaCataract
- First Posted Date
- 2019-03-29
- Last Posted Date
- 2022-05-12
- Lead Sponsor
- RxSight, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT03895034
- Locations
- π²π½
CODET Vision Institute, Tijuana, Mexico
- Prev
- 1
- 2
- Next